Biomerica, Inc.
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.8M | $-5.0M | $-6.0M | $-7.1M | $-4.5M | $-7.4M | $-2.7M | $-2.4M |
| Depreciation & Amortization | $77.0K | $87.0K | $81.0K | $84.0K | $339.0K | $105.0K | $105.3K | $101.2K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $20.0K | $21.0K | $18.0K | $18.0K | $239.0K | $34.0K | $23.9K | $61.7K |
| Stock-Based Compensation | $476.0K | $460.0K | $837.0K | $1.2M | $1.3M | — | — | — |
| Net Cash from Operating Activities | $-3.4M | $-3.8M | $-5.4M | $-5.5M | $-479.0K | $-5.3M | $-4.3M | $-2.2M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $51.0K | $64.0K | $57.0K | $135.9K | $33.6K | $101.1K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-1.0K | $-37.0K | $-115.0K | $-78.0K | $-170.0K | $-295.6K | $-118.9K | $-171.1K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $2.3M | $2.1M | $-81.0K | $9.4M | $2.4M | $1.1M | $12.4M | $1.9M |
| Net Change in Cash | $-1.1M | $-1.8M | $-5.5M | $3.8M | $1.7M | $-4.4M | $8.0M | $-518.1K |
| Free Cash Flow | — | — | $-5.4M | $-5.5M | $-536.0K | $-5.4M | $-4.3M | $-2.3M |